A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology

AIMS: ATI-2042 (budiodarone) is a chemical analogue of amiodarone with a half life of 7 h. It is electrophysiologically similar to amiodarone, but may not have metabolic and interaction side effects. The sophisticated electrocardiograph logs of advanced DDDRP pacemakers were used to monitor the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arya, Anita, Silberbauer, John, Teichman, Sam L., Milner, Peter, Sulke, Neil, Camm, A. John
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659603/
https://www.ncbi.nlm.nih.gov/pubmed/19174378
http://dx.doi.org/10.1093/europace/eun384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659603/
https://www.ncbi.nlm.nih.gov/pubmed/19174378
http://dx.doi.org/10.1093/europace/eun384

Ejemplares similares